LFG
IRON icon

Larson Financial Group’s Disc Medicine IRON Stock Holding History

Larson Financial Group’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Hold
123
– – ﹤0.01% 2471
2026
Q1 		$7.87K Buy
123
+11
+10% +$763 ﹤0.01% 2372
2025
Q4 		$8.89K Buy
112
+4
+4% +$338 ﹤0.01% 2181
2025
Q3 		$7.14K Sell
108
-1
-0.9% -$59 ﹤0.01% 2202
2025
Q2 		$5.77K Buy
+109
New +$5.12K ﹤0.01% 2028
2025
Q1 		– Sell
-68
Closed -$4.31K – 3143
2024
Q4 		$4.31K Buy
+68
New +$3.93K ﹤0.01% 1704

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Larson Financial Group's IRON Position: Q2 2026 in Review

Larson Financial Group held its Disc Medicine (IRON) position steady in Q2 2026 at 123 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Larson Financial Group first reported a position in IRON in Q4 2024 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Larson Financial Group held 123 shares of Disc Medicine worth $9K as of Q2 2026.
  • Larson Financial Group left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2471 holding.
  • Larson Financial Group first reported a position in Disc Medicine in Q4 2024 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.